Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
Details for Australian Patent Application No. 2002349327 (hide)
International Classifications
Event Publications
13 March 2003 Complete Application Filed
Priority application(s): 01204465.7 09.11.01 EP
24 July 2003 Application Open to Public Inspection
Published as AU-B-2002349327
23 October 2008 Application Accepted
Published as AU-B-2002349327
19 February 2009 Standard Patent Sealed
3 November 2011 Assignment Registered
Janssen Pharmaceutica N.V. The patent has been assigned to Elanco Animal Health Ireland Limited
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002349328-Valuable document and security mark using a marking substance
2002349326-Utilization of phosphatidylserine in the treatment of attention deficit syndrome (ADHS)
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser